Terms: = Kidney tumors AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Prognosis
3 results:
1. A meta-analysis of the platelet-lymphocyte ratio: A notable prognostic factor in renal cell carcinoma.
Zhou X; Luo G
Int J Biol Markers; 2022 Jun; 37(2):123-133. PubMed ID: 35238678
[TBL] [Abstract] [Full Text] [Related]
2. Mast cell density in metastatic renal cell carcinoma: Association with prognosis and tumour-infiltrating lymphocytes.
Yao J; Xi W; Chen X; Xiong Y; Zhu Y; Wang H; Hu X; Guo J
Scand J Immunol; 2021 Apr; 93(4):e13006. PubMed ID: 33275792
[TBL] [Abstract] [Full Text] [Related]
3. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract] [Full Text] [Related]
